DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Scriptaid
Scriptaid
Histone Deacetylase Inhibitors: an Attractive Therapeutic Strategy Against Breast Cancer
Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities
Mechanisms and Clinical Significance of Histone Deacetylase Inhibitors: Epigenetic Glioblastoma Therapy
Direct Amidation to Access 3-Amido-1,8-Naphthalimides Including Fluorescent Scriptaid Analogues As HDAC Inhibitors
Histone Deacetylase Inhibitors for the Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia
China Japan United States Europe
Characterizing Heterogeneous Cellular Responses to Perturbations
S13229-020-00387-6.Pdf
Histone Deacetylase Inhibitor Scriptaid Reactivates Latent HIV-1 Promoter by Inducing Histone Modification in in Vitro Latency Cell Lines
Anti-Tumor Activity of Phenoxybenzamine and Its Inhibition of Histone Deacetylases
A Database for Histone Deacetylase Inhibitors
Uncovering Active Modulators of Native Macroautophagy Through
Valproic Acid Inhibits Proliferation of HER2-Expressing Breast Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis Through Hsp70 Acetylation
A Gene-Signature Progression Approach to Identifying Candidate Small-Molecule Cancer Therapeutics with Connectivity Mapping Qing Wen1, Chang-Sik Kim1,2, Peter W
Intrinsic and Extrinsic Molecular Determinants Or Modulators For
Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus
Scriptaid, a Novel Histone Deacetylase Inhibitor, Enhances the Response of Human Tumor Cells to Radiation
Histone Deacetylase Inhibitors
Top View
Original Article Protective Effects of Histone Deacetylase Inhibition by Scriptaid on Brain Injury in Neonatal Rat Models of Cerebral Ischemia and Hypoxia
Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
WO 2016/118775 Al 28 July 2016 (28.07.2016) W P O P C T
High-Throughput Identification of Post-Transcriptional Utrophin Up
Anticancer Effect of Histone Deacetylase Inhibitor Scriptaid As a Single Agent for Hepatocellular Carcinoma
WO 2015/034925 Al 12 March 2015 (12.03.2015) P O P C T
CBP/P300 Acetyltransferases Regulate the Expression of NKG2D Ligands on Tumor Cells
Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury Via Modulation of PTEN and AKT Pathway
Histone Deacetylase Inhibitors: Apoptotic Effects and Clinical Implications (Review)
Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells
Screening for Epigenetic Inhibitors of Osteosarcoma
Synergistic Antitumor Effects of Histone Deacetylase Inhibitor Scriptaid and Bortezomib Against Ovarian Cancer Cells
2016REIMS026.Pdf
Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
Figure 1 METHODS and COMPOSITIONS for the TREATMENT of DISORDERS ASSOCIATED with DEFECTS of the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE OR PROTEIN
Histone Deacetylase Inhibitor Scriptaid Induces Cell Cycle Arrest and Epigenetic Change in Colon Cancer Cells
Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
Improved Cloning Efficiency by Chemically Induced Metabolic Reprogramming of Donor Cells Used for Porcine Somatic Cell Nuclear Transfer
Activity of Epigenetic Inhibitors Against Plasmodium Falciparum Asexual And
Differential Response of Cancer Cells to HDAC Inhibitors Trichostatin a and Depsipeptide
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
Section Page Experimental Methods and Materials S1-S3 Supplemental References S3 Figures S4-S7 Tables S8-S13 HRMS and NMR Spectra S14-S58
(12) Patent Application Publication (10) Pub. No.: US 2004/0077591 A1 Dangond (43) Pub
Working Party of National Coordinators of the Test Guidelines Programme
Gene Expression Signature-Based Approach Identifies a Pro-Resolving
The Histone Deacetylase Inhibitor Panobinostat Is a Potent Antitumor Agent in Canine Diffuse Large B-Cell Lymphoma